drugset / Trial / NCT02515305

Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne Vulgaris

NCT02515305

Phase 3 Completed 890 enrolled Padagis LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the safety and efficacy of Perrigo's product to an FDA approved product for the treatment acne vulgaris

Timeline

Start
2015-07
Primary completion
2016-04
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Benzoyl Peroxide Other / unclassified
Subject Clindamycin Unknown

Indications